Adenotonsillectomy Boosts Growth and Sleep Quality in Children with Mild Breathing Problems

Can Adenotonsillectomy Improve Growth and Sleep in Children?

Adenotonsillectomy significantly improves growth and sleep parameters in children with mild sleep-disordered breathing (SDB), according to a secondary analysis of a randomized controlled trial. The study, which evaluated 330 children aged 3-12 years with mild SDB, found that surgical intervention resulted in measurable gains in height and weight percentiles compared to watchful waiting, alongside improvements in key sleep metrics after 12 months.

The findings, derived from the Pediatric Adenotonsillectomy Trial for Snoring (PATS), represent the first comprehensive assessment of growth outcomes following adenotonsillectomy (AT) specifically in children with mild SDB. While previous research has established AT as the primary treatment for obstructive sleep apnea (OSA), this study extends potential benefits to children with milder forms of sleep-disordered breathing who were previously considered to have a benign condition. The researchers demonstrated that after adjusting for baseline measurements, children in the AT group showed an increase of 2.74 percentiles in height and 2.79 percentiles in weight compared to the watchful waiting group at the 12-month follow-up. The surgical intervention also led to improvements in sleep parameters, including reductions in the obstructive apnea-hypopnea index (OAHI), respiratory disturbance index (RDI), and oxygen desaturation index (ODI).

Who Benefits Most from Adenotonsillectomy?

The impact of AT on growth was particularly pronounced among specific subgroups. The most significant height gains were observed in children aged 3-5 years (mean difference: 7.88 percentiles), those with grade III or IV tonsillar hypertrophy (mean difference: 5.40 percentiles), and non-asthmatic children (mean difference: 4.24 percentiles). Boys appeared to benefit more than girls in terms of height gain, though the researchers noted this sex-specific difference requires further investigation. Interestingly, while AT was associated with slight increases in BMI percentiles overall, this effect was not significant among children who were already at or above the 85th percentile for BMI at baseline, alleviating concerns about potential weight-related complications in overweight or obese children.

What Do the Experts Say About the Underlying Mechanisms?

Dr. Fang Fang, one of the study authors, explained the potential mechanisms behind these findings: "Even mild SDB can lead to sleep instability and fragmentation, which may disrupt growth hormone secretion. By alleviating upper airway obstruction, adenotonsillectomy appears to improve sleep quality and reduce intermittent hypoxia, creating favorable conditions for growth." The improvements in sleep architecture, specifically decreased Stage 1 sleep and increased Stage 2 sleep, further support this hypothesis, as these changes indicate better sleep quality and reduced sleep fragmentation. The study also found that children with higher baseline respiratory disturbance indices or oxygen desaturation indices showed more pronounced growth benefits from surgery, suggesting that the degree of breathing disruption during sleep correlates with potential growth improvement after intervention.

Could These Findings Change Clinical Management of Mild SDB?

The PATS trial was initially designed to evaluate the effects of AT on executive function and behavior in children with mild SDB, but this secondary analysis provides additional evidence for considering surgical intervention even in milder cases. Previous clinical practice has typically limited AT to cases of moderate-to-severe OSA or recurrent tonsillitis, with watchful waiting often recommended for children with primary snoring or mild SDB. These findings may prompt clinicians to reconsider this approach, particularly for younger children with tonsillar hypertrophy who show signs of growth concerns alongside mild SDB symptoms.

In terms of sleep architecture improvements, the study revealed that children in the AT group experienced a reduction in Stage 1 sleep percentage (mean difference: -1.00) and an increase in Stage 2 sleep percentage (mean difference: 2.06) compared to the watchful waiting group. These changes in sleep architecture suggest improved sleep quality following surgical intervention. The researchers also observed improvements in the arousal index, peak End-tidal carbon dioxide (EtCO₂), and average oxygen saturation, although these differences did not reach statistical significance.

The study defined mild SDB as habitual snoring occurring more than three nights per week with an OAHI of ≤ 3, with 70% of the study population having an OAHI of < 1 (median 0.6). This is significant because it demonstrates that even children with very mild sleep-disordered breathing may benefit from surgical intervention. The researchers conducted several sensitivity analyses, including one restricted to children with an OAHI of < 1, which yielded similar results to the main analysis, further supporting the potential benefits of AT even in children with primary snoring.

What Are the Study Limitations and Future Research Directions?

Despite these promising results, the researchers acknowledged several limitations, including the relatively short 12-month follow-up period, which prevents assessment of long-term growth trajectories, and the lack of growth biomarkers such as insulin-like growth factor-1 (IGF-1) measurements, which could have provided insights into the underlying biological mechanisms. Additionally, the study population was predominantly white (70.8%), potentially limiting generalizability to more diverse populations. Future research with longer follow-up periods and more diverse study populations will be necessary to fully understand the sustained benefits of AT for children with mild SDB.

Industry Context: This study emerges amid growing recognition that even mild sleep-disordered breathing can have significant health implications beyond the immediately observable symptoms. The findings align with a broader shift in pediatric sleep medicine toward earlier intervention and recognition of SDB's systemic effects on growth, cognition, and behavior. As healthcare systems increasingly focus on preventive care and early interventions to avoid long-term health complications, these results may influence clinical guidelines and insurance coverage policies regarding surgical interventions for children with milder forms of SDB, potentially expanding access to adenotonsillectomy for a broader patient population.

Summary

A secondary analysis of the Pediatric Adenotonsillectomy Trial for Snoring (PATS) has demonstrated that adenotonsillectomy significantly improves growth and sleep parameters in children with mild sleep-disordered breathing. The study evaluated 330 children aged 3-12 years and found that surgical intervention resulted in measurable gains in height and weight percentiles compared to watchful waiting after 12 months. Children in the adenotonsillectomy group showed increases of 2.74 percentiles in height and 2.79 percentiles in weight, alongside improvements in key sleep metrics including reductions in the obstructive apnea-hypopnea index, respiratory disturbance index, and oxygen desaturation index. The most significant height gains were observed in children aged 3-5 years, those with grade III or IV tonsillar hypertrophy, and non-asthmatic children. The study suggests that even mild sleep-disordered breathing can disrupt growth hormone secretion through sleep instability and fragmentation, and that adenotonsillectomy improves sleep quality by reducing intermittent hypoxia. These findings may prompt clinicians to reconsider current practice patterns that typically limit surgical intervention to moderate-to-severe cases, particularly for younger children with tonsillar hypertrophy who show signs of growth concerns. The researchers noted limitations including the relatively short 12-month follow-up period and lack of growth biomarkers, emphasizing the need for future research with longer follow-up periods and more diverse study populations to fully understand the sustained benefits of adenotonsillectomy for children with mild sleep-disordered breathing.